I'm hoping that we get another offer, or rejection by the
I'm hoping that we get another offer, or rejection by the Institutions that really control the vote. I'm purchasing cheap calls in the hope that I'm right.
The penalty was put in place to prevent this, however if a company that's interested agrees with me that IMGN should be worth $40 or more a share the penalty will be a small part of their overall offer. Nothing would serve us better than a bidding war for IMGN.
I feel that whatever is to happen will do so by July, so July calls at $32 and $33 have been my target of choice at no more than a dime, many at a nickel.
Gary
1
ImmunoGen Inc. (IMGN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Nokia Partners with Telin for Enhanced Data Center Connectivity In an exciting collaboration, Telin has chosen Nokia as its partner to improve data center interconnectivity across Singapore. This partnership aims to create exceptional networking solutions for businesses, particularly helping major tech enterprises and hyperscalers optimize their operations. Transforming...
Continue Reading
Ammo Inc hit a rough patch back in 2024, dropping to a 52-week low of $20.69. This wasn’t just some isolated hiccup; it was the tip of the iceberg showing deeper issues lurking beneath the surface. Year-on-year, we’re looking at a decline of -4.12%, which means investors were scrambling to figure out how this company planned to navigate through all this chaos and win...
Continue Reading
PropGenie's Entry Revolutionizes Prop Firm Branding If you've ever rubbed elbows in the prop firm world, you know it's a jungle out there. Launching a prop firm demands more than a savvy trader instinct—it's a branding beatdown fraught with hurdles. Enter PropGenie, an innovation from PropAccount.com that might just wipe away some of those sweat beads. A Game-Changer...
Continue Reading
Transforming Cancer Care with Value-Based Innovations Outcomes Matter Innovations has taken a significant step in enhancing the quality of oncology care by launching a groundbreaking value-based care program in collaboration with Regional Cancer Care Associates (RCCA). This partnership is set to reshape the cancer treatment landscape, focusing on patient-centered care...
Continue Reading
Ranpak Holdings Corp. Scheduled to Share Q3 Results Ranpak Holdings Corp. (NYSE: PACK) has announced its intent to release third quarter financial results, making an important connection with investors and stakeholders alike. This significant event is set to unfold on a Thursday morning at approximately 7:30 a.m. (ET) on the last day of October. Details of the Conference...
Continue Reading
